4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000243
EVP, Chief Business Officer sold 15,000 shares at $68.01 ($1,020,210)
- EVP, Chief Business Officer acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $31.80 | $477,000 | 46,926 | D |
| 2025-10-02 | Sale : show line 2 in the form 10b5-1 | −15,000 | $68.01 | $1,020,210 | 31,926 | D |
| Open-market sales · 15,000 sh · avg $68.01 · $1,020,210 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-02 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −15,000 | 26,700 | D |
Loading xslF345X05/edgardoc.xml…